No abstract available.
Intracranial Hemorrhage, Hypertensive*

No abstract available.
Intracranial Hemorrhage, Hypertensive*

A male patient aged 52 was admitted due to an attack to manage the hypertensive intracerebral hematoma at the left subfrontal region. An operation of supraorbital keyhole approach via a superciliary skin incision was performed. Result showed a shortened surgical time of a minimal invasion, almost hematoma was removed completely. Post-operative status was stable and the patient was discharged with GOC score of 5
Intracranial Hemorrhage, Hypertensive ; Intracranial Hemorrhages ; surgery ; Therapeutics

No abstract available.
Hemorrhage* ; Intracranial Hemorrhage, Hypertensive ; Trigeminal Nerve Diseases

69 patients with hypertensive intracerebral hemorrhage (HICH) admitted within 24 hours of stroke onset. 14/69 patients (20.3%) with enlarged hematomas after the first CT was performed during 30 minutes at admission and the second within 24-36 hours of admission (33%). Multivariate analyses revealed that the following three factors were independently associated with hematoma enlargement: the time from stroke onset, prothrombin ratio, the shape of hematoma. Hematoma enlargement was an independent factor increasing the mortality rate in the HICH patients
Hematoma ; Diagnosis ; Intracranial Hemorrhage, Hypertensive ; Hypertension

Although the relationship between hypertension and intracerebral hemorrhage is well established, the mechanism which precipitates definitely arterial rupture and the natural course of hematoma in the brain have long been disputed. In this article, the literatures regarding the etiology and pathogenesis of hypertensive intracerebral hemorrhage were reviewed.
Brain ; Cerebral Hemorrhage ; Hematoma ; Hypertension ; Intracranial Hemorrhage, Hypertensive* ; Rupture

Intracerebral hemorrhage(ICH) following aneurysmal rupture is found in 34% of the previous literature. However, hypertensive ICH concurrent with subarachnoid hemorrhage(SAH) due to an aneurysm rupture is very unusual with only four cases, to our knowledge, having been previously reported in the literature. We describe a patient who presented with aneurysmal SAH concurrent with hypertensive ICH and review of the literature.
Aneurysm* ; Humans ; Intracranial Hemorrhage, Hypertensive* ; Rupture ; Subarachnoid Hemorrhage*

From March 1997 – September 2002, study on 31 patients intracerebral hemorrhage (28 male, 3 female) and 16 patients of control group (14 male, 2 female). The mortality of surgical treatment group was 32% and control group was 56%. Most of the benefit was in patients with lobar hemorrhage and following criteria: volume of hematoma  60cc, age  70, GCS  8. These is some suggestion that in the next future the treatment of intracerebral hemorrhage will involve non-invasive, stereotactic aspiration of hemorrhage through a single burr hole within hours
Intracranial Hemorrhage ; Hypertensive ; Surgery ; Cerebral Hemorrhage, Traumatic ; therapeutics ; surgery

The purpose of this study is to characterize the recurrence and to investigate the risk factors for the recurrence in the 989 patients who had hypertensive intracerebral hemorrhage between 1989-1995. Fifty-three patients(5.4%) had two episodes of hemorrhage with median interval of 22.3+16.3 months(range, 1.7-71.9 months). The probable risk of recurrent hemorrhage was the highest within two years of the first hemorrhage, being 3.6 % in the first year and 3.5 % in the second year. The sites of the recurrent hemorrhage were different from the initial site in all patients. The common patterns of recurrence were "ganglionic(putamen/caudate nucleus)-thalamic" in 26.8% and "ganglionic-ganglionic in 21.4%. The "lobar-lobar" pattern was noted in only 2 patients, The overall mortality was 28.3%. In patients who had ganglionic-ganglionic pattern, the mortality was significantly inc reased (p<0.005). No recurrent hemorrhage occurred during the regular treatment for hypertension. The only significant tactor for recurrent hemorrhage was the antihypertensive therapy of less than 3 months after the initial attack(p<0.005). Considering lifelong treatment for hypertension, long-term regular control for hypertension will be required to prevent the recurrent hemorrhage.
Hemorrhage ; Humans ; Hypertension ; Intracranial Hemorrhage, Hypertensive ; Mortality ; Recurrence ; Risk Factors

OBJECTIVE: Hypertensive intracerebral hemorrhage is a potentially life-threatening neurological deficit with the highest morbidity and mortality. In recent years, neuroendoscopy has been used to treat intracerebral hemorrhages (ICHs). However, the choice of neuroendoscopic surgery or craniotomy for patients with ICHs is controversial. The objective of this meta-analysis was to assess the efficacy of neuroendoscopic surgery compared to craniotomy in patients with supratentorial hypertensive ICH.MATERIALS AND METHODS: A systematic electronic search was performed using online electronic databases such as Pubmed, Embase, and Cochrane library updated on December 2017. The meta-analysis was performed by only including studies designed as randomized controlled trials.RESULTS: Three randomized controlled trials met our inclusion criteria. Pooled analysis of death showed that neuroendoscopic surgery decreased the rate of death compared to craniotomy (RR=0.58, 95% CI: 0.26–1.29; P=0.18). Pooled results of complications showed that neuroendoscopic surgery tended to have fewer complications than craniotomy had (RR=0.37, 95% CI: 0.28–0.49; P < 0.0001).CONCLUSION: Although the presenting analyses suggest that neuroendoscopic surgery should have fewer complications than craniotomy dose, it had no superior advantage in morbidity rate definitely. Therefore, it may be necessary for the neurosurgeons to select best optimal patients for individual treatment.
Cerebral Hemorrhage ; Craniotomy ; Humans ; Intracranial Hemorrhage, Hypertensive ; Mortality ; Neuroendoscopy ; Neurosurgeons